By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo

TheMediTary.Com

Medical Information, Documents, News - TheMediTary.Com

  • Home
  • News
  • Drugs
  • Drugs A-Z
  • Medical Answers
  • About Us
  • Contact
Medical Information, Documents, News - TheMediTary.Com Logo Medical Information, Documents, News - TheMediTary.Com Logo
Search Drugs
  • Drugs
    • Latest Drugs
    • Drugs A-Z
    • Medical Answers
  • News
    • FDA Alerts
    • Medical News
    • Health
    • Consumer Updates
    • Children's Health
  • More TheMediTary.Com
    • About Us
    • Contact
Follow US
Home > Drugs > Factor xa (recombinant), inactivated-zhzo (monograph) > Factor xa (recombinant), inactivated-zhzo (monograph) Side Effects
Drugs

Coagulation factor Xa Side Effects

Applies to coagulation factor Xa: intravenous powder for solution.

Warning

Intravenous route (Powder for Solution)

Thromboembolic Risks, Ischemic Risks, Cardiac Arrest, and Sudden DeathsTreatment with coagulation factor Xa (recombinant) IV injection has been associated with serious and life-threatening adverse events, including:Arterial and venous thrombolic eventsIschemic events, including myocardial infarction and ischemic strokeCardiac arrestSudden deathsMonitor for thromboembolic events and initiate anticoagulation when medically appropriate. Monitor for symptoms and signs that precede cardiac arrest and provide treatment as needed.

Serious side effects

Along with its needed effects, coagulation factor Xa may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor or nurse immediately if any of the following side effects occur while taking coagulation factor Xa:

More common

  • Anxiety
  • blue lips, fingernails, or skin
  • chest pain or discomfort
  • confusion
  • cool, sweaty skin
  • cough
  • decreased urine output
  • difficulty in speaking
  • dilated neck veins
  • dizziness
  • double vision
  • extreme tiredness or weakness
  • fainting
  • fast heartbeat
  • headache
  • inability to move the arms, legs, or facial muscles
  • inability to speak
  • irregular heartbeat
  • irregular, fast or slow, or shallow breathing
  • lightheadedness
  • nausea
  • pain or discomfort in the arms, jaw, back, or neck pain
  • redness, or swelling in the arm or leg
  • slow speech
  • sweating
  • swelling of the face, fingers, feet, or lower legs
  • tightness in the chest
  • troubled breathing
  • vomiting
  • weakness
  • weight gain

Less common

  • Fast, pounding, or irregular heartbeat or pulse
  • palpitations

Other side effects

Some side effects of coagulation factor Xa may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

More common

  • Bladder pain
  • bloody or cloudy urine
  • change in taste
  • chills
  • cough
  • difficult, burning, or painful urination
  • feeling of warmth
  • fever
  • frequent urge to urinate
  • loss of taste
  • lower back or side pain
  • redness of the face, neck, arms, and occasionally, upper chest
  • sneezing
  • sore throat

For Healthcare Professionals

Applies to coagulation factor Xa: intravenous powder for injection.

General

The most common adverse reactions (5% or greater) were urinary tract infections and pneumonia.[Ref]

Other

Very common (10% or more): Infusion-related reactions (18%), death prior to day 30 follow-up (14%)

Common (1% to 10%): Sudden death

Frequency not reported: Feeling hot[Ref]

In the ongoing ANNEXA-4 study, there were 25 deaths (14%) prior to the day 30 follow-up visit. The percentage of patients, by bleeding type, who died prior to the day 30 follow-up was: 14% for intracranial bleeding, 10% for gastrointestinal bleeding, and 19% for other bleeding types.[Ref]

Immunologic

Very common (10% or more): Antibodies against this drug (up to 17%)[Ref]

Cardiovascular

Common (1% to 10%): Deep vein thrombosis, acute myocardial infarction, cardiogenic shock, congestive heart failure

Uncommon (0.1% to 1%): Cardiac arrest, cardiac thrombus, iliac artery thrombosis, non-sustained ventricular tachycardia

Frequency not reported: Flushing[Ref]

Respiratory

Common (1% to 10%): Pulmonary embolism, acute respiratory failure

Frequency not reported: Cough, dyspnea, pneumonia[Ref]

Genitourinary

Frequency not reported: Urinary tract infection[Ref]

Dermatologic

Frequency not reported: Mild hives[Ref]

Nervous system

Common (1% to 10%): Ischemic stroke

Uncommon (0.1% to 1%): Embolic stroke

Frequency not reported: Dysgeusia[Ref]

Share this Article
Latest News
Medical News

Shingles vaccine may lower heart disease risk by up to 8 years

May 09, 2025
Obesity, unhealthy lifestyles may cause heart to age by 5–45 years
Aging: As little as 5 minutes of exercise may keep the brain healthy
Prostate cancer: Simple urine test may help with early detection
Cancer treatment side effects: Exercise may reduce pain, fatigue
Alzheimer's: Exercising in middle age may reduce beta-amyloid in brain...
Related Drugs
Fidanacogene Elaparvovec
Cerave Anti-Itch
Centrum Adult
Crovalimab
Cyltezo Prefilled Syringe
Zepbound Pen
Mylanta One
Uretron Ds
Medihoney Wound And Burn Dressing
Lidotrode

Other drugs

Name Drug Class Updated
Fidanacogene Elaparvovec Drugs 03-Oct-2024
Cerave Anti-Itch Drugs 02-Oct-2024
Centrum Adult Drugs 02-Oct-2024
Crovalimab Drugs 02-Oct-2024
Cyltezo Prefilled Syringe Drugs 01-Oct-2024
Zepbound Pen Drugs 30-Sep-2024
Mylanta One Drugs 27-Sep-2024
Uretron Ds Drugs 27-Sep-2024
Medihoney Wound And Burn Dressing Drugs 26-Sep-2024
Lidotrode Drugs 26-Sep-2024
Libervant Drugs 26-Sep-2024
Moderna Covid-19 Drugs 25-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024
Beqvez Drugs 24-Sep-2024

Categories

  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health

About US

Welcome to TheMediTary.Com

Our website provides reliable and up-to-date information on various medical topics. We empower individuals to take charge of their health by simplifying complex medical jargon and providing practical tips and advice. We prioritize the privacy and confidentiality of our users and welcome feedback to improve our services.

Website use data of FDA and other sources

DMCA.com Protection Status Truste Protection Status Trust Mark Protection Status
HONcode logo We comply with the HONcode standard for trustworthy health information.
Quick Link
  • About Us
  • Contact Us
  • Editorial Policy
  • Privacy Policy
  • Accessibility Policy
  • Terms & Conditions
  • Disclaimer
  • DMCA
  • Do Not Sell My Personal Information
  • Sitemap
  • Care Notes
  • Health Guide
  • Professional
Drugs
  • New Drugs
  • Medical Answers
  • Drugs A-Z
  • Drug Classes
  • Drug Dosage
  • Pill Identifier
  • Consumer Infor
  • Side Effects
  • Inactive Ingredients
  • Pregnancy Warnings
  • Patient Tips
  • Treatments
News
  • Latest News
  • FDA Alerts
  • Medical News
  • Health
  • Consumer Updates
  • Children's Health
Find US
  • Medium
  • Google Site
  • Blogspot
  • API
  • Reddit
  • Tumblr
  • Scoop.it
  • Substack
  • Wordpress
  • Wix
  • Behance

© 2025 TheMediTary.Com All rights reserved. Operated by